ClinicalTrialsFinder

High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer Clinical Trials in Durham, North Carolina

1 recruitingDurham, North Carolina

Showing 1–1 of 1 trials

Recruiting
Phase 2

A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer

High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc310 enrolled91 locationsNCT05128825